                         SEQUENCE LISTING

<110>  SORICIMED BIOPHARMA INC.
 
<120>  USE OF C-TERMINAL SORICIDIN PEPTIDES FOR THE TREATMENT OR 
       PREVENTION OF SARS-COV2 INFECTION

<130>  15309-P62396PC00

<150>  US 63/070,525
<151>  2020-08-26

<160>  7     

<170>  PatentIn version 3.5

<210>  1
<211>  13
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic construct

<400>  1

Lys Glu Phe Leu His Pro Ser Lys Val Asp Leu Pro Arg 
1               5                   10              


<210>  2
<211>  27
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic construct

<400>  2

Glu Gly Lys Leu Ser Ser Asn Asp Thr Glu Gly Gly Leu Cys Lys Glu 
1               5                   10                  15      


Phe Leu His Pro Ser Lys Val Asp Leu Pro Arg 
            20                  25          


<210>  3
<211>  9
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic construct

<400>  3

His Pro Ser Lys Val Asp Leu Pro Arg 
1               5                   


<210>  4
<211>  6
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic construct

<400>  4

Lys Val Asp Leu Pro Arg 
1               5       


<210>  5
<211>  5
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic construct

<400>  5

Val Asp Leu Pro Arg 
1               5   


<210>  6
<211>  14
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic construct

<400>  6

Cys Lys Glu Phe Leu His Pro Ser Lys Val Asp Leu Pro Arg 
1               5                   10                  


<210>  7
<211>  11
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic construct

<400>  7

Phe Leu His Pro Ser Lys Val Asp Leu Pro Arg 
1               5                   10      


